Metropolis Healthcare Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on August 13, 2025
METROPOLIS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Metropolis Healthcare has informed the exchanges that its 25th Annual General Meeting (AGM) will be held on Wednesday, August 13, 2025, at 10:00 a.m. (IST) via video conferencing, along with the attached Annual Report for FY 2024-25. The company reported total revenue of ₹1,331 crore (up 12% year-on-year), adjusted EBITDA of ₹325 crore (up 14%) with a 24.4% margin, and adjusted profit after tax of ₹161 crore (up 26%). It served 12.67 million+ patients and processed 26.43 million+ tests during the year, while expanding its network to 750+ towns and 4,500+ service points. The company also strengthened its North India presence with the acquisition of Core Diagnostics (Delhi NCR) and announced acquisitions of Scientific Pathology (Agra) and Dr. Ahuja's Pathology & Imaging Centre (Dehradun). Leadership changes include the elevation of Ameera Shah to Executive Chairperson and Surendran Chemmenkotil to Managing Director, with Dr. Sushil Shah moving to Chairman Emeritus.
The filing is a routine regulatory disclosure of the AGM and annual report, but it gives shareholders a detailed view of FY25 performance showing double-digit revenue and profit growth. Key takeaways for investors are the strong margin profile, the strategic pause on heavy capex for FY26 to consolidate recent acquisitions, and the focus on shifting the business mix toward higher-value B2C and specialty diagnostics—all of which could support a positive re-rating if execution stays on track.